Human scleral hydraulic conductivity: Age-related changes, topographical variation, and potential scleral outflow facility

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 11, 2006, Pages 4942-4946

  Jackson, Timothy L ^a,b   Hussain, Ali ^a   Hodgetts, Andrea ^a   Morley, Ana M S ^a,b   Hillenkamp, Jost ^a,c   Sullivan, Paul M ^b   Marshall, John ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTARALDEHYDE; WATER;

ADOLESCENT; ADULT; AGE; AGED; AGING; ARTICLE; BIOREACTOR; CALCULATION; CHILD; CORE TEMPERATURE; DEVICE; HUMAN; HUMAN TISSUE; HYDRAULIC CONDUCTIVITY; INTRAOCULAR PRESSURE; MICROSCOPY; PRIORITY JOURNAL; SCLERA; THICKNESS; USSING CHAMBER; VISCOSITY; WATER COLUMN; WATER FLOW; DIFFUSION CHAMBER; FEMALE; MALE; METABOLISM; MIDDLE AGED; PERMEABILITY; PHYSIOLOGY; PRESCHOOL CHILD; TRANSPORT AT THE CELLULAR LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL TRANSPORT; CHILD; CHILD, PRESCHOOL; DIFFUSION CHAMBERS, CULTURE; FEMALE; HUMANS; MALE; MIDDLE AGED; PERMEABILITY; SCLERA; WATER;

EID: 34247146386     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0362     Document Type: Article

References (39)

1. Weinreb RN, Toris CB, Gabelt BT, et al. Effects of prostaglandins on the aqueous humor outflow pathways. Surv Ophthalmol. 2002;47(suppl 1):S53-S64.
2. Dan JA, Honavar SG, Belyea DA, et al. Enzymatic sclerostomy: pilot human study. Arch Ophthalmol. 2002;120:548-553.
3. Myles ME, Neumann DM, Hill JM. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis. Adv Drug Deliv Rev. 2005;57:2063-2079.
4. Ambati J, Gragoudas ES, Miller JW, et al. Transscleral delivery of bioactive protein to the choroid and retina. Invest Ophthalmol Vis Sci. 2000;41:1186-1191.
5. Gass JD. Uveal effusion syndrome: a new hypothesis concerning pathogenesis and technique of surgical treatment. Trans Am Ophthalmol Soc. 1983;81:246-260.
6. Ward RC, Gragoudas ES, Pon DM, Albert DM. Abnormal scleral findings in uveal effusion syndrome. Am J Ophthalmol. 1988;106:139-146.
7. Forrester JV, Lee WR, Kerr PR, Dua HS. The uveal effusion syndrome and trans-scleral flow. Eye. 1990;4:354-365.
8. Uyama M, Takahashi K, Kozaki J, et al. Uveal effusion syndrome: clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology. Ophthalmology. 2000;107:441-449.
9. Johnson M, Erickson K. Mechanisms and routes of aqueous humor drainage. In: Albert DM, Jakobeic FA, eds. Principles and Practice of Ophthalmology. 2nd ed. Philadelphia: WB Saunders, 2000: 2577-2595.
10. Fatt I, Hedbys BO. Flow of water in the sclera. Exp Eye Res. 1970;10:243-249.
11. Starita C, Hussain AA, Patmore A, Marshall J. Localization of the site of major resistance to fluid transport in Bruch's membrane. Invest Ophthalmol Vis Sci. 1997;38:762-767.
12. Antcliff RJ, Hussain AA, Marshall J. Hydraulic conductivity in fixed retinal tissue after sequential excimer laser ablation. Arch Ophthalmol. 2001;119:539-544.
13. Jackson TL, Antcliff RJ, Hillenkamp J, Marshall J. Human retinal molecular weight exclusion limit and estimate of species variation. Invest Ophthalmol Vis Sci. 2003;44:2141-4.
14. Rudnick DE, Noonan JS, Geroski DH, et al. The effect of intraocular pressure on human and rabbit scleral permeability. Invest Ophthalmol Vis Sci. 1999;40:3054-3058.
15. Lee SB, Geroski DH, Prausnitz MR, Edelhauser HF. Drug delivery through the sclera: effects of thickness, hydration, and sustained release systems. Exp Eye Res. 2004;78:599-607.
16. Olsen TW, Aaberg SY, Geroski DH, Edelhauser HF. Human sclera: thickness and surface area. Am J Ophthalmol. 1998;125:237-241.
17. Olsen TW, Sanderson S, Feng X, Hubbard WC. Porcine sclera: thickness and surface area. Invest Ophthalmol Vis Sci. 2002;43:2529-2532.
18. Levick JR. Flow through interstitium and other fibrous matrices. Q J Exp Physiol. 1987;72:409-437.
19. Emi K, Pederson JE, Toris CB. Hydrostatic pressure of the suprachoroidal space. Invest Ophthalmol Vis Sci. 1989;30:233-238.
20. Brown CT, Vural M, Johnson M, Trinkaus-Randall V. Age-related changes of scleral hydration and sulfated glycosaminoglycans. Mech Ageing Dev. 1994;77:97-107.
21. Rada JA, Achen VA, Penugonda S, et al. Proteoglycan composition in the human sclera during growth and aging. Invest Ophthalmol Vis Sci. 2000;41:1639-1648.
22. Boubriak OA, Urban JPG, Bron AJ. Differential effects of aging on transport properties of anterior and posterior human sclera. Exp Eye Res. 2003;76:701-713.
23. Overby D, Ruberti J, Gong H, et al. Specific hydraulic conductivity of corneal stroma as seen by quick-freeze/deep-etch. J Biomech Eng. 2001;123:154-161.
24. Weinreb RN. Enhancement of scleral macromolecular permeability with prostaglandins. Trans Am Ophthalmol Soc. 2001;99:319-343.
25. Boubriak OA, Urban JP, Akhtar S, et al. The effect of hydration and matrix composition on solute diffusion in rabbit sclera. Exp Eye Res. 2000;71:503-514.
26. Ambati J, Canakis CS, Miller JW, et al. Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci. 2000;41:1181-1185.
27. Kao JC, Geroski DH, Edelhauser HF. Transscleral permeability of fluorescent-labeled antibiotics. J Ocul Pharmacol Ther. 2005;21:1-10.
28. Tai MC, Lu DW, Chiang CH. Corneal and scleral permeability of quinolones: a pharmacokinetics study. J Ocul Pharmacol Ther. 2003;19:547-554.
29. Urdu N, Robinson JR. Scleral permeability to hydrocortisone and mannitol in the albino rabbit eye. J Ocul Pharmacol Ther. 1998;14:273-281.
30. Okabe K, Kimura H, Okabe J, et al. Effect of benzalkonium chloride on transscleral drug delivery. Invest Ophthalmol Vis Sci. 2005;46:703-708.
31. Mora P, Eperon S, Felt-Baeyens O, et al. Trans-scleral diffusion of triamcinolone acetonide. Curr Eye Res. 2005;30:355-361.
32. Eljarrat-Binstock E, Raiskup F, Frucht-Pery J, Domb AJ. Transcorneal and transscleral iontophoresis of dexamethasone phosphate using drug loaded hydrogel. J Control Release. 2005;106:386-390.
33. Cruysberg LP, Nuijts RM, Gilbert JA, et al. In vitro sustained human transscleral drug delivery of fluorescein-labeled dexamethasone and methotrexate with fibrin sealant. Curr Eye Res. 2005;30:653-660.
34. Robinson MR, Lee SS, Kim H, et al. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide. Exp Eye Res. 2006;82:479-487.
35. Cruysberg LP, Franklin AJ, Sanders J, et al. Effective transscleral delivery of two retinal anti-angiogenic molecules: carboxyamidotriazole (CAI) and 2-methoxyestradiol (2ME2). Retina. 2005;25:1022-1031.
36. Amaral J, Fariss RN, Campos MM, et al. Transscleral-RPE permeability of PEDF and ovalbumin proteins: implications for subconjunctival protein delivery. Invest Ophthalmol Vis Sci. 2005;46:4383-4392.
37. Toris CB, Yablonski ME, Wang YL, Camras CB. Aqueous humor dynamics in the aging human eye. Am J Ophthalmol. 1999;127:407-412.
38. Bill A, Wålinder PE. The aqueous effects of pilocarpine on the dynamics of aqueous humor in a primate (Macaca irus). Invest Ophthalmol. 1966;5:170-175.
39. Kelly DE, Hageman GS, McGregor JA. Uveal compartmentalization in the hamster eye revealed by fine structural and tracer studies: implications for uveoscleral outflow. Invest Ophthalmol Vis Sci. 1983;24:1288-1304.